Found: 2
Select item for more details and to access through your institution.
Thioredxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 4, p. 627, doi. 10.1007/s10637-010-9401-y
- By:
- Publication type:
- Article
Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo.
- Published in:
- Investigational New Drugs, 2010, v. 28, n. 3, p. 205, doi. 10.1007/s10637-009-9235-7
- By:
- Publication type:
- Article